blog

NICHD Solicits Feedback on Strategic Plan
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has issued a Request for Information (RFI) to solicit feedback on its new strategic plan. Read full article
blog

New Female Condom: How to Interest Providers and Retailers
To address barriers to uptake of the Woman’s Condom, the USAID-funded EECO project paired a consumer-facing marketing campaign, led by PSI, with provider-facing marketing by medical detail... Read full article
blog

Microneedle patches designed to deliver long-acting contraceptive hormone
Sustained hormonal release of a contraceptive hormone may be possible via the use of biodegradable levonorgestrel-releasing microneedle patches, according to a newly published paper. Read full article
blog

FDA plans new office to revamp drug review process
US FDA announced plans to create the Office of Drug Evaluation Science in an effort to improve how new medicines are currently reviewed. Read full article
blog

International Conference on Family Planning
The fifth International Conference on Family Planning (ICFP) was held in November in Kigali, Rwanda. Contraceptive technology innovation was highlighted throughout the week. Read full article
blog

Launch of first clinical trial for male contraceptive gel
Three sites in the U.S. started enrolling couples in the first-ever clinical trial to test the safety and efficacy of a gel for men to prevent unintended pregnancy. Read full article
blog

Celebrating #NextGenContraception on World Contraception Day
The CTI Exchange joins global partners in celebrating World Contraception Day. To celebrate, we are pleased to share highlights from our recent #NextGenContraception campaign. Read full article
blog

FDA approvals for Annovera and Natural Cycles app
On August 10, 2018, the U.S. Food and Drug Administration made two major announcements related to contraception. The FDA permitted marketing of Natural Cycles and it approved AnnoveraTM. Read full article
blog

Newly Published: Can WIN 18,446 function as a nonhormonal female contraceptive? 
Vitamin A deficient women produce less retinoic acid, and this deficiency reduces their fertility. Meanwhile, the compound WIN 18,446 inhibits retinoic acid production. WIN 18,446 has a... Read full article
blog

A Summer in Contraceptive Development
This summer, we got to work in CTI as undergraduate interns. We knew we were going to be working in contraceptive research and development (R&D), but there were far fewer lab coats and chemi... Read full article
blog

New Summer Twitter Campaign: #NextGenContraception
The CTI Exchange’s summer social media campaign aims to highlight the importance of new contraceptive research and development to meet the needs and preferences of women and men globally. ... Read full article
blog

Report on the International Family Planning Landscape
The Center for Global Development (CGD) and Kaiser Family Foundation (KFF) held an international family planning leadership retreat to discuss the current landscape of the field. Read full article